WHO EUL Facilitated Procedure for accelerating National listing of SARS CoV-2 IVDs

Overview

The WHO Emergency Use Listing (EUL) is a risk-based mechanism for assessing and listing medical products, including in vitro diagnostics (IVDs) which aim to accelerate the availability of IVDs to member states during public health emergencies of international concern (PHEIC). The mechanism was used to assess medical products during previous epidemics, including Ebola Virus Disease (2014-2016), Zika Virus (2015-2016), and the current COVID-19 pandemic.